SCHEMBL3676607

SCHEMBL3676607

N=C(c1ccccc1)c1ccccc1-c1cccc2c1Cc1ccccc1-2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.46
HTR2B P41595 2/20 0.46
PNMT P11086 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HSP90AA1 P07900 2/20 0.40
SRD5A2 P31213 1/20 0.39
DRD2 P14416 2/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
PPARG P37231 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CYP1A2 P05177 1/20 0.36
ADRA1D P25100 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3676088 0.85 PNMT (0.38) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL3681430 0.83 RAB9A (0.36) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL21758198 0.79 HSP90AA1 (0.56) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL3672074 0.79 PNMT (0.38) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL3679002 0.79 HTR2B (0.44) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL30103334 0.78 PNMT (0.63) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL524602 0.78 PNMT (0.63) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL3674178 0.77 PNMT (0.42) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL28635892 0.76 HTR2B (0.59) HTR7HTR2BPNMTNPC1RAB9A
SCHEMBL2877998 0.75 PNMT (0.61) HTR7HTR2BPNMTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732643-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME HANAOKA HIDENORI 2010-02-25 US disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 HTR7 3440/4885HTR2B 2177/4885PNMT 1804/4885
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME C1R, C1S, AP1M1 HTR7 3440/4885HTR2B 2177/4885PNMT 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.